Screen-detected breast cancers have an improved 5-year recurrence free interval compared to interval and non-screened breast cancers: a population-based study

被引:0
|
作者
de Munck, L. [1 ]
Eijkelboom, A. [1 ]
Otten, H. [2 ]
Broeders, M. [3 ]
Siesling, S. [1 ]
机构
[1] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Hlth Evidence, Med Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Hlth Evidence, Med Ctr, Dutch Expert Ctr Screening, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
97 (PB-097
引用
收藏
页码:S31 / S31
页数:1
相关论文
共 50 条
  • [41] Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers
    Defossez, Gautier
    Quillet, Alexandre
    Ingrand, Pierre
    BMC CANCER, 2018, 18
  • [42] Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers
    Henderson, Louise M.
    Miglioretti, Diana L.
    Kerlikowske, Karla
    Wernli, Karen J.
    Sprague, Brian L.
    Lehman, Constance D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (03) : 676 - 684
  • [43] Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers
    Tvedskov, Tove F.
    Jensen, Maj-Britt
    Balslev, Eva
    Garne, Jens P.
    Vejborg, Ilse
    Christiansen, Peer
    Ejlertsen, Bent
    Kroman, N.
    ACTA ONCOLOGICA, 2016, 55 (04) : 455 - 459
  • [44] Comparison of radiological and histopathological features between interval and screen-detected breast cancers: a retrospective case–control study
    Anna Maria Schirano
    Livia Dell’Aquila
    Giuseppe Melucci
    Roberto Galeotti
    Journal of Medical Imaging and Interventional Radiology, 11 (1):
  • [45] A comparative analysis of risk factor associations with interval and screen-detected breast cancers: A large UK prospective study
    Barnes, Isobel
    Garcia-Closas, Montserrat
    Gathani, Toral
    Sweetland, Sian
    Floud, Sarah
    Reeves, Gillian K.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (06) : 979 - 987
  • [46] Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme
    Timmermans, Lore
    Bleyen, Luc
    Bacher, Klaus
    Van Herck, Koen
    Lemmens, Kim
    Van Ongeval, Chantal
    Van Steen, Andre
    Martens, Patrick
    De Brabander, Isabel
    Goossens, Mathieu
    Thierens, Hubert
    EUROPEAN RADIOLOGY, 2017, 27 (09) : 3810 - 3819
  • [47] Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme
    Lore Timmermans
    Luc Bleyen
    Klaus Bacher
    Koen Van Herck
    Kim Lemmens
    Chantal Van Ongeval
    Andre Van Steen
    Patrick Martens
    Isabel De Brabander
    Mathieu Goossens
    Hubert Thierens
    European Radiology, 2017, 27 : 3810 - 3819
  • [48] Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds
    Nguyen, Tuong L.
    Aung, Ye K.
    Li, Shuai
    Nhut Ho Trinh
    Evans, Christopher F.
    Baglietto, Laura
    Krishnan, Kavitha
    Dite, Gillian S.
    Stone, Jennifer
    English, Dallas R.
    Song, Yun-Mi
    Sung, Joohon
    Jenkins, Mark A.
    Southey, Melissa C.
    Giles, Graham G.
    Hopper, John L.
    BREAST CANCER RESEARCH, 2018, 20
  • [49] Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program
    Marisa Baré
    Núria Torà
    Dolores Salas
    Melchor Sentís
    Joana Ferrer
    Josefa Ibáñez
    Raquel Zubizarreta
    Garbiñe Sarriugarte
    Teresa Barata
    Laia Domingo
    Xavier Castells
    Maria Sala
    Breast Cancer Research and Treatment, 2015, 154 : 403 - 415
  • [50] Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program
    Bare, Marisa
    Tora, Nuria
    Salas, Dolores
    Sentis, Melchor
    Ferrer, Joana
    Ibanez, Josefa
    Zubizarreta, Raquel
    Sarriugarte, Garbine
    Barata, Teresa
    Domingo, Laia
    Castells, Xavier
    Sala, Maria
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (02) : 403 - 415